The global esomeprazole market is experiencing steady growth due to the increasing prevalence of gastrointestinal disorders and the growing demand for effective acid suppression therapies. Esomeprazole, a proton pump inhibitor (PPI), is widely prescribed for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, Zollinger-Ellison syndrome, and other acid-related...